vs
Side-by-side financial comparison of AstroNova, Inc. (ALOT) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $39.2M, roughly 1.9× AstroNova, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -3.4%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $3.3M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 2.1%).
AstroNova, Inc. is a global technology firm designing, manufacturing and distributing specialty data visualization products, including high-performance label printers, test and measurement equipment, and aerospace-grade data recording systems, serving aerospace, manufacturing, retail and healthcare markets worldwide.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
ALOT vs PBYI — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.2M | $75.5M |
| Net Profit | $378.0K | — |
| Gross Margin | 36.2% | 69.3% |
| Operating Margin | 3.3% | 22.7% |
| Net Margin | 1.0% | — |
| Revenue YoY | -3.4% | 27.7% |
| Net Profit YoY | 221.5% | — |
| EPS (diluted) | $0.05 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.2M | $75.5M | ||
| Q3 25 | $36.1M | $54.5M | ||
| Q2 25 | $37.7M | $52.4M | ||
| Q1 25 | — | $46.0M | ||
| Q4 24 | $40.4M | $59.1M | ||
| Q3 24 | $40.5M | $80.5M | ||
| Q2 24 | $33.0M | $47.1M | ||
| Q1 24 | $39.6M | $43.8M |
| Q4 25 | $378.0K | — | ||
| Q3 25 | $-1.2M | $8.8M | ||
| Q2 25 | $-376.0K | $5.9M | ||
| Q1 25 | — | $3.0M | ||
| Q4 24 | $240.0K | — | ||
| Q3 24 | $-311.0K | $20.3M | ||
| Q2 24 | $1.2M | $-4.5M | ||
| Q1 24 | $2.7M | $-4.8M |
| Q4 25 | 36.2% | 69.3% | ||
| Q3 25 | 32.2% | 77.7% | ||
| Q2 25 | 33.6% | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | 33.9% | 76.4% | ||
| Q3 24 | 35.3% | 63.9% | ||
| Q2 24 | 36.3% | 77.4% | ||
| Q1 24 | 31.9% | 75.5% |
| Q4 25 | 3.3% | 22.7% | ||
| Q3 25 | -2.0% | 17.6% | ||
| Q2 25 | 1.5% | 12.7% | ||
| Q1 25 | — | 8.7% | ||
| Q4 24 | 3.1% | 22.6% | ||
| Q3 24 | 2.6% | 27.4% | ||
| Q2 24 | 4.1% | -4.6% | ||
| Q1 24 | 9.9% | -5.3% |
| Q4 25 | 1.0% | — | ||
| Q3 25 | -3.4% | 16.2% | ||
| Q2 25 | -1.0% | 11.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | -0.8% | 25.2% | ||
| Q2 24 | 3.6% | -9.6% | ||
| Q1 24 | 6.8% | -11.0% |
| Q4 25 | $0.05 | $0.26 | ||
| Q3 25 | $-0.16 | $0.17 | ||
| Q2 25 | $-0.05 | $0.12 | ||
| Q1 25 | — | $0.06 | ||
| Q4 24 | $0.03 | $0.40 | ||
| Q3 24 | $-0.04 | $0.41 | ||
| Q2 24 | $0.15 | $-0.09 | ||
| Q1 24 | $0.37 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $3.6M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $76.9M | $130.3M |
| Total Assets | $140.8M | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.6M | $97.5M | ||
| Q3 25 | $3.9M | $94.4M | ||
| Q2 25 | $5.4M | $96.0M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | $4.4M | $101.0M | ||
| Q3 24 | $4.8M | $96.7M | ||
| Q2 24 | $4.0M | $96.8M | ||
| Q1 24 | $4.5M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $76.9M | $130.3M | ||
| Q3 25 | $75.8M | $115.3M | ||
| Q2 25 | $76.6M | $104.7M | ||
| Q1 25 | — | $97.1M | ||
| Q4 24 | $92.2M | $92.1M | ||
| Q3 24 | $91.8M | $71.1M | ||
| Q2 24 | $91.2M | $48.5M | ||
| Q1 24 | $90.3M | $51.0M |
| Q4 25 | $140.8M | $216.3M | ||
| Q3 25 | $143.1M | $202.9M | ||
| Q2 25 | $150.3M | $194.9M | ||
| Q1 25 | — | $196.2M | ||
| Q4 24 | $166.5M | $213.3M | ||
| Q3 24 | $169.0M | $220.7M | ||
| Q2 24 | $126.6M | $205.0M | ||
| Q1 24 | $133.3M | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $14.4M |
| Free Cash FlowOCF − Capex | $3.3M | $14.4M |
| FCF MarginFCF / Revenue | 8.5% | 19.1% |
| Capex IntensityCapex / Revenue | 0.2% | 0.0% |
| Cash ConversionOCF / Net Profit | 9.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.9M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $14.4M | ||
| Q3 25 | $249.0K | $9.7M | ||
| Q2 25 | $4.4M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-4.7M | $15.6M | ||
| Q3 24 | $162.0K | $11.0M | ||
| Q2 24 | $6.9M | $1.0M | ||
| Q1 24 | $6.5M | $11.2M |
| Q4 25 | $3.3M | $14.4M | ||
| Q3 25 | $202.0K | $9.7M | ||
| Q2 25 | $4.3M | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | $-5.0M | $15.6M | ||
| Q3 24 | $-176.0K | $11.0M | ||
| Q2 24 | $6.4M | $1.0M | ||
| Q1 24 | $6.0M | — |
| Q4 25 | 8.5% | 19.1% | ||
| Q3 25 | 0.6% | 17.7% | ||
| Q2 25 | 11.5% | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | -12.4% | 26.4% | ||
| Q3 24 | -0.4% | 13.7% | ||
| Q2 24 | 19.5% | 2.1% | ||
| Q1 24 | 15.3% | — |
| Q4 25 | 0.2% | 0.0% | ||
| Q3 25 | 0.1% | 0.0% | ||
| Q2 25 | 0.2% | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.6% | 0.0% | ||
| Q3 24 | 0.8% | 0.0% | ||
| Q2 24 | 1.5% | 0.0% | ||
| Q1 24 | 1.0% | 0.0% |
| Q4 25 | 9.05× | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | -19.76× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 5.85× | — | ||
| Q1 24 | 2.38× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALOT
| Public Utilities Inventory Supplies | $20.6M | 53% |
| Hardware Products | $12.7M | 32% |
| Service And Other | $5.9M | 15% |
PBYI
Segment breakdown not available.
